SELECTIVE INHIBITOR OF EXON 20 INSERTION MUTANT EGFR

• 收藏
• 分享

专利权人:

Taiho Pharmaceutical Co.; Ltd.

发明人:

Kazutaka Miyadera,Yoshimi Aoyagi,Shinichi Hasako

申请号：

US16345792

公开号：

US20190262345A1

申请日:

2017.10.31

申请国别(地区):

US

年份:

2019

代理人:

摘要：

An antitumor agent comprising a compound selected from the group consisting of Compounds A to D described in the specification, or a salt thereof, for treating a malignant tumor patient expressing EGFR having exon 20 insertion mutation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/